Aggelos Athanasopoulos

Suggest Changes
We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.

Writes About:

Learn More
An appreciable percentage of patients with relapsed/refractory germ-cell tumors (GCTs), candidates for high-dose chemotherapy (HDC) and autologous hematopoietic cell transplantation (HCT), fail to(More)
6540 Background: HDC followed by AHSCT represents a curative treatment option in certain relapsed solid tumors and lymphomaslymphomas. Our current report evaluates the mobilizing potential of VIP CT(More)
High-dose chemotherapy and hematopoietic stem cell support remains a valuable treatment option for the rare patient population with relapsed Wilms' tumor. Here we report the case of a 22-year-old(More)
High-dose chemotherapy and hematopoietic stem cell support remains a curative treatment option for relapsed or nonresponsive germ cell tumors, and has been applied experimentally to control severe(More)
  • 1